Antiphospholipase A2 receptor autoantibodies: A comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Behnert, Astrid ^a   Schiffer, Mario ^a   Müller Deile, Janina ^a   Beck, Laurence H ^b   Mahler, Michael ^c   Fritzler, Marvin J ^d  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INOVA DIAGNOSTICS INC   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; PHOSPHOLIPASE A2 RECEPTOR;

ADDRESSABLE LASER BEAD IMMUNOASSAY; ANTIBODY DETECTION; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GRANULOMATOSIS; HUMAN; IDIOPATHIC MEMBRANOUS NEPHROPATHY; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; IMMUNOTHERAPY; IN VIVO STUDY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEMBRANOUS GLOMERULONEPHRITIS; PROTEIN EXPRESSION; PROTEINURIA; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; TURNAROUND TIME; BLOOD; CASE CONTROL STUDY; GLOMERULONEPHRITIS, MEMBRANOUS; IMMUNOLOGY; PROCEDURES; REFERENCE VALUE; REPRODUCIBILITY;

AUTOANTIBODIES; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; IMMUNOASSAY; RECEPTORS, PHOSPHOLIPASE A2; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 84900333461     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/143274     Document Type: Article

References (16)

1. Beck L. H. Jr., Bonegio R. G. B., Lambeau G., Beck D. M., Powell D. W., Cummins T. D., Klein J. B., Salant D. J., M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. The New England Journal of Medicine 2009 361 1 11 21 2-s2.0-67649658244 10.1056/NEJMoa0810457
2. Hofstra J. M., Debiec H., Short C. D., Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. Journal of the American Society of Nephrology 2012 23 1735 1743
3. Debiec H., Martin L., Jouanneau C., Dautin G., Mesnard L., Rondeau E., Mousson C., Ronco P., Autoantibodies specific for the phospholipase A2 receptor in recurrent and de novo membranous nephropathy. American Journal of Transplantation 2011 11 10 2144 2152 2-s2.0-80053301363 10.1111/j.1600-6143. 2011.03643.x
4. Hofstra J. M., Wetzels J. F., Anti-PLA2R antibodies in membranous nephropathy: ready for routine clinical practice? Netherlands Journal of Medicine 2012 70 3 109 113 2-s2.0-84860144475
5. Qin W., Beck L. H. Jr., Zeng C., Chen Z., Li S., Zuo K., Salant D. J., Liu Z., Anti-phospholipase A2 receptor antibody in membranous nephropathy. Journal of the American Society of Nephrology 2011 22 6 1137 1143 2-s2.0-79957745793 10.1681/ASN.2010090967
6. Svobodova B., Honsova E., Ronco P., Tesar V., Debiec H., Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. Nephrology Dialysis Transplantation 2013 28 7 1839 1844 10.1093/ndt/gfs439
7. Hoxha E., Harendza S., Zahner G., Panzer U., Steinmetz O., Fechner K., Helmchen U., Stahl R. A. K., An immunofluorescence test for phospholipase-A2- receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrology Dialysis Transplantation 2011 26 8 2526 2532 2-s2.0-79961085790 10.1093/ndt/gfr247
8. Debiec H., Ronco P., Nephrotic syndrome: a new specific test for idiopathic membranous nephropathy. Nature Reviews Nephrology 2011 7 9 496 498 2-s2.0-80052259467 10.1038/nrneph.2011.106
9. Hofstra J. M., Beck L. H. Jr., Beck D. M., Wetzels J. F., Salant D. J., Anti-phospholipase a2 receptor antibodies correlatewith clinical status in idiopathic membranous nephropathy. Clinical Journal of the American Society of Nephrology 2011 6 6 1286 1291 2-s2.0-79958186439 10.2215/CJN.07210810
10. Behnert A., Fritzler M. J., Teng B., An anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptor. PLoS ONE 2013 8 e61669
11. Fritzler M. J., Advances and applications of multiplexed diagnostic technologies in autoimmune diseases. Lupus 2006 15 7 422 427 2-s2.0-33746625215 10.1191/0961203306lu2327oa (Pubitemid 44147087)
12. Fritzler M. J., Fritzler M. L., The emergence of multiplexed technologies as diagnostic platforms in systemic autoimmune diseases. Current Medicinal Chemistry 2006 13 21 2503 2512 2-s2.0-33748556839 10.2174/092986706778201639 (Pubitemid 44364152)
13. Dahnrich C., Komorowski L., Probst C., Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy. Clinica Chimica Acta 2013 421 213 218
14. Kanigicherla D., Gummadova J., McKenzie E. A., Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney International 2013 83 5 940 948 10.1038/ki.2012.486
15. Beck L. H., Salant D. J., Membranous nephropathy: recent travels and new roads ahead. Kidney International 2010 77 9 765 770 2-s2.0-77951090624 10.1038/ki.2010.34
16. Mahler M., Gascon C., Patel S., Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay. Arthritis Research & Therapy 2013 15 2, article R50